J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims

Más como este

• Justicia23/09/2026@LawDesk

  Baltimore Jury Orders J&J to Pay $1.56 Billion Over Baby Powder Cancer

  Clarence M. Mitchell Jr. Courthouse, 100 North Calvert Street, Baltimore, Maryland 21202, United States

  Empieza el 22/12/2025CONFIRMADO81% DE CONFIANZAhace 275 díasThe Baltimore Banner's report of Tuesday 23 December 2025 says "The jury returned the verdict in favor of Cherie Craft ... on Monday in Baltimore Circuit Court", i.e. Monday 22 December 2025 (Bloomberg: "Jurors in state court in Baltimore late Monday"); no time of day is reported, so the pin is all day.^[1]

  A Baltimore City jury awarded Cherie Craft $59.84 million in compensatory and $1.5 billion in punitive damages, finding J&J's talc baby powder exposed her to the asbestos behind her peritoneal mesothelioma - the largest talc verdict for a single plaintiff. J&J said it would appeal.

  $1.6B

  0.69

  00
• Empresas23/09/2026@HealthDesk

  J&J Completes Its $1 Billion Acquisition of Firefly Bio

  South San Francisco, San Mateo County, California, United StatesJohnson & Johnson·…

  

  Empieza el 29/07/2026CONFIRMADO87% DE CONFIANZAhace 56 días"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ^[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".

  Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.

  $1B

  0.65

  00
• Salud23/09/2026@HealthDesk

  J&J Signs a Drug-Pricing Deal With Trump and Joins TrumpRx

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  Empieza el 08/01/2026CONFIRMADO86% DE CONFIANZAhace 258 díasJ&J's release is datelined "New Brunswick, N.J. – JANUARY 8, 2026" and says the company "today announced a voluntary agreement with the Trump Administration"; coverage followed on 9 January.^[1]

  Johnson & Johnson signed a voluntary most-favored-nation drug-pricing agreement with the Trump administration, selling medicines through TrumpRx.gov and to Medicaid at prices comparable to other developed countries in exchange for an exemption from pharmaceutical tariffs, and announced two new US plants in Pennsylvania and North Carolina.

  0.64

  00
• Empresas23/09/2026@HealthDesk

  Apollo in Talks to Buy J&J's DePuy Synthes for About $20 Billion

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  Empieza el 11/09/2026CONFIRMADO82% DE CONFIANZAhace 12 díasThe disclosure is Bloomberg's report, dated "September 11, 2026" (Yahoo's^[1][2][5] syndicated copy went up at 22:26 UTC and quotes Friday's closing share prices); Reuters' write-up the same evening says "Bloomberg News reported on Friday", and Quartz's 14 September story is a follow-up, so the pin is the all-day 11 September.

  Bloomberg reported that Apollo Global Management is in talks to buy DePuy Synthes, J&J's $9.3 billion-a-year orthopaedics unit, at a value close to $20 billion, with a deal possible within weeks though J&J could still spin the unit off instead.

  $20B

  0.64

  00
• Salud23/09/2026@HealthDesk

  J&J Announces Plan to Spin Off DePuy Synthes

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  Empieza el 14/10/2025CONFIRMADO90% DE CONFIANZAhace 344 díasThe release is datelined "NEW BRUNSWICK, NJ, October 14, 2025 - Johnson & Johnson ... today announced the Company's intent to separate its Orthopaedics business"; it states no time of day (CNBC's^[3] report was up at 6:29 a.m. EDT and J&J's X post at 6:40 a.m. EDT), so the pin is the all-day 14 October.

  Johnson & Johnson said it would separate its roughly $9.2 billion-a-year orthopaedics business into a standalone company called DePuy Synthes within 18 to 24 months, and named former Smith & Nephew chief Namal Nawana to run it.

  0.63

  00
• Salud23/09/2026@HealthDesk

  DePuy Synthes se separa de Johnson & Johnson

  325 Paramount Drive, Raynham, Massachusetts 02767, United StatesJohnson & Johnson·…

  

  Empieza el 01/07/2027ESTIMADO71% DE CONFIANZAdentro de 281 díasEl 10-Q de J&J correspondiente al trimestre cerrado el 28 de junio de 2026 fija como objetivo la "finalización en un plazo de 18 a 24 meses tras el anuncio inicial" del 14 de octubre de 2025 (de mediados de abril a mediados de octubre de 2027), y el director financiero Joseph Wolk dijo en julio que J&J "avanza según lo previsto hacia una separación a mediados de 2027" (Bloomberg); "mediados de 2027" se interpreta como la mitad del año, el 1 de julio de 2027, que cae dentro de esa ventana.^[1]

  El negocio de ortopedia de Johnson & Johnson saldrá del grupo como DePuy Synthes —mediante una escisión libre de impuestos o mediante una venta, con Apollo en conversaciones por unos 20.000 millones de dólares— y J&J afirma que la separación va camino de completarse a mediados de 2027.

  0.62

  00
• Salud23/09/2026@HealthDesk

  J&J Picks Wilson, North Carolina for a Second 500-Job Drug Plant

  Wilson, Wilson County, North Carolina, United StatesJohnson & Johnson·…

  

  Empieza el 09/01/2026CONFIRMADO87% DE CONFIANZAhace 257 díasThe governor's release is dated "Friday, January 9, 2026" and begins "Today Governor Josh Stein announced Johnson & Johnson ... will expand its presence in North Carolina"; the Wilson Times^[3] says Stein "made the announcement Friday afternoon".

  North Carolina Governor Josh Stein announced that Johnson & Johnson will build a second multibillion-dollar plant in Wilson, a drug product manufacturing facility for cancer and neurology medicines expected to create up to 500 jobs, beside the $2 billion biologics campus it is already building there.

  0.61

  00
• Derecho23/09/2026@LawDesk

  Google and DOJ Due to File a Joint Proposed Final Judgment in Ad Tech Case

  Albert V. Bryan United States Courthouse, 401 Courthouse Square, Alexandria, VA 22314, United StatesGoogle·…

  

  Empieza el 02/10/2026PROGRAMADO86% DE CONFIANZAdentro de 9 díasThe court's 2 September 2026 order (ECF 1857) directs the parties to "file one jointly proposed Final Judgment" "within 30 days of the date of this Order", which falls on 2 October 2026, and AdExchanger^[1] reports "Both parties have until October 2 to submit their proposed final judgments".

  Google and the Justice Department must file one jointly proposed Final Judgment in the ad tech antitrust case by 2 October 2026, writing Judge Brinkema's behavioral remedies into an order that takes effect 60 days after she enters it.

  0.61

  00
• Salud23/09/2026@HealthDesk

  Abbott Settles DOJ Infant Formula Claims for $385 Million

  Abbott Laboratories·…Sturgis, Saint Joseph County, Michigan, 49091, United States

  Empieza el 14/09/2026CONFIRMADO88% DE CONFIANZAhace 9 díasThe release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]

  Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.

  $385M

  0.60

  00
• Finanzas23/09/2026@HealthDesk

  J&J Q2 2026 Results: $25.3B Sales, 2026 Outlook Raised

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  Empieza el 15/07/2026 12:30CONFIRMADO83% DE CONFIANZAhace 70 díasConfirmed by J&J's release dated "New Brunswick, N.J. (July 15, 2026)", which says it "will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time" (12:30 UTC; the edited transcript is stamped "JULY 15, 2026 / 12:30PM GMT").^[1]

  Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.

  0.60

  00
• Salud23/09/2026@HealthDesk

  Lilly Agrees to Acquire Centessa for Up to $7.8 Billion

  Eli Lilly·…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States

  Empieza el 31/03/2026CONFIRMADO87% DE CONFIANZAhace 176 díasThe joint release is datelined "INDIANAPOLIS and BOSTON and LONDON, March 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Centessa".^[1]

  Lilly agrees to buy Centessa Pharmaceuticals, maker of the orexin agonist cleminorexton for narcolepsy, for $38 a share in cash (about $6.3 billion) plus a CVR worth up to $1.5 billion more; the deal closed on 24 June 2026.

  $7.8B

  0.59

  00
• Justicia23/09/2026@LawDesk

  Judge Approves the DOJ's HPE-Juniper Settlement Over States' Objections

  Robert F. Peckham United States Courthouse and Federal Building, 280 South 1st Street, San Jose, California 95113, United States

  

  Empieza el 12/08/2026CONFIRMADO85% DE CONFIANZAhace 42 díasThe order granting the motion for entry of final judgment (Case 5:25-cv-00951-PCP, Document 482) is 'Filed 08/12/26' and signed 'Dated: August 12, 2026' by P. Casey Pitts; no time is given, so it is an all-day date.^[1]

  Judge P. Casey Pitts entered the consent decree clearing HPE's Juniper Networks deal in a 41-page order that found DOJ leadership overrode its own antitrust staff, but held that 12 states and DC had not shown the Instant On sale and Mist source-code licence were against the public interest.

  0.59

  00